 | • レポートコード：QYR9ST09570 • 出版社/出版日：QYResearch / 2019年9月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、神経障害性疼痛管理の世界市場について調査・分析し、神経障害性疼痛管理の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（三環系抗うつ薬、抗痙攣薬、オピオイド、ステロイド薬、局所麻酔、その他）、用途別（小売薬局、病院薬局、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の神経障害性疼痛管理市場動向 ・主要企業別マーケットシェア ・神経障害性疼痛管理の種類別市場規模2014-2019 （三環系抗うつ薬、抗痙攣薬、オピオイド、ステロイド薬、局所麻酔、その他） ・神経障害性疼痛管理の用途別市場規模2014-2019 （小売薬局、病院薬局、その他） ・神経障害性疼痛管理の北米市場：主要企業・種類別/用途別市場規模 ・神経障害性疼痛管理のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・神経障害性疼痛管理の中国市場：主要企業・種類別/用途別市場規模 ・神経障害性疼痛管理の日本国内市場：主要企業・種類別/用途別市場規模 ・神経障害性疼痛管理の東南アジア市場：主要企業・種類別/用途別市場規模 ・神経障害性疼痛管理のインド市場：主要企業・種類別/用途別市場規模 ・神経障害性疼痛管理の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Pfizer、Johnson & Johnson Services、Sanofi、GlaxoSmithKline、Eli Lilly and Company、Bristol-Myers Squibb、Biogen Idec、Baxter Healthcare Corporation、Depomed） ・神経障害性疼痛管理の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Neuropathic pain management refers to a way to relieve and treat neuropathic pain through various drugs or treatments.In 2018, the global Neuropathic Pain Management market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Neuropathic Pain Management status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neuropathic Pain Management development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Pfizer
Johnson & Johnson Services
Sanofi
GlaxoSmithKline
Eli Lilly and Company
Bristol-Myers Squibb
Biogen Idec
Baxter Healthcare Corporation
Depomed
Market segment by Type, the product can be split into
Tricyclic Antidepressant
Anticonvulsant
Opioid
Steroid Drug
Local Anesthesia
Other
Market segment by Application, split into
Retail Pharmacy
Hospital Pharmacy
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Neuropathic Pain Management status, future forecast, growth opportunity, key market and key players.
To present the Neuropathic Pain Management development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Neuropathic Pain Management are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Neuropathic Pain Management Market Size Growth Rate by Type (2014-2025)
1.4.2 Tricyclic Antidepressant
1.4.3 Anticonvulsant
1.4.4 Opioid
1.4.5 Steroid Drug
1.4.6 Local Anesthesia
1.4.7 Other
1.5 Market by Application
1.5.1 Global Neuropathic Pain Management Market Share by Application (2019-2025)
1.5.2 Retail Pharmacy
1.5.3 Hospital Pharmacy
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Neuropathic Pain Management Market Size
2.2 Neuropathic Pain Management Growth Trends by Regions
2.2.1 Neuropathic Pain Management Market Size by Regions (2019-2025)
2.2.2 Neuropathic Pain Management Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Neuropathic Pain Management Market Size by by Players
3.1.1 Global Neuropathic Pain Management Revenue by by Players (2014-2019)
3.1.2 Global Neuropathic Pain Management Revenue Market Share by by Players (2014-2019)
3.1.3 Global Neuropathic Pain Management Market Concentration Ratio (CR5 and HHI)
3.2 Neuropathic Pain Management Key Players Head office and Area Served
3.3 Key Players Neuropathic Pain Management Product/Solution/Service
3.4 Date of Enter into Neuropathic Pain Management Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Neuropathic Pain Management Market Size by Type (2014-2019)
4.2 Global Neuropathic Pain Management Market Size by Application (2014-2019)
5 North America
5.1 North America Neuropathic Pain Management Market Size (2014-2019)
5.2 Neuropathic Pain Management Key Players in North America
5.3 North America Neuropathic Pain Management Market Size by Type
5.4 North America Neuropathic Pain Management Market Size by Application
6 Europe
6.1 Europe Neuropathic Pain Management Market Size (2014-2019)
6.2 Neuropathic Pain Management Key Players in Europe
6.3 Europe Neuropathic Pain Management Market Size by Type
6.4 Europe Neuropathic Pain Management Market Size by Application
7 China
7.1 China Neuropathic Pain Management Market Size (2014-2019)
7.2 Neuropathic Pain Management Key Players in China
7.3 China Neuropathic Pain Management Market Size by Type
7.4 China Neuropathic Pain Management Market Size by Application
8 Japan
8.1 Japan Neuropathic Pain Management Market Size (2014-2019)
8.2 Neuropathic Pain Management Key Players in Japan
8.3 Japan Neuropathic Pain Management Market Size by Type
8.4 Japan Neuropathic Pain Management Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Neuropathic Pain Management Market Size (2014-2019)
9.2 Neuropathic Pain Management Key Players in Southeast Asia
9.3 Southeast Asia Neuropathic Pain Management Market Size by Type
9.4 Southeast Asia Neuropathic Pain Management Market Size by Application
10 India
10.1 India Neuropathic Pain Management Market Size (2014-2019)
10.2 Neuropathic Pain Management Key Players in India
10.3 India Neuropathic Pain Management Market Size by Type
10.4 India Neuropathic Pain Management Market Size by Application
11 Central & South America
11.1 Central & South America Neuropathic Pain Management Market Size (2014-2019)
11.2 Neuropathic Pain Management Key Players in Central & South America
11.3 Central & South America Neuropathic Pain Management Market Size by Type
11.4 Central & South America Neuropathic Pain Management Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Neuropathic Pain Management Introduction
12.1.4 Pfizer Revenue in Neuropathic Pain Management Business (2014-2019))
12.1.5 Pfizer Recent Development
12.2 Johnson & Johnson Services
12.2.1 Johnson & Johnson Services Company Details
12.2.2 Company Description and Business Overview
12.2.3 Neuropathic Pain Management Introduction
12.2.4 Johnson & Johnson Services Revenue in Neuropathic Pain Management Business (2014-2019)
12.2.5 Johnson & Johnson Services Recent Development
12.3 Sanofi
12.3.1 Sanofi Company Details
12.3.2 Company Description and Business Overview
12.3.3 Neuropathic Pain Management Introduction
12.3.4 Sanofi Revenue in Neuropathic Pain Management Business (2014-2019)
12.3.5 Sanofi Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Company Details
12.4.2 Company Description and Business Overview
12.4.3 Neuropathic Pain Management Introduction
12.4.4 GlaxoSmithKline Revenue in Neuropathic Pain Management Business (2014-2019)
12.4.5 GlaxoSmithKline Recent Development
12.5 Eli Lilly and Company
12.5.1 Eli Lilly and Company Company Details
12.5.2 Company Description and Business Overview
12.5.3 Neuropathic Pain Management Introduction
12.5.4 Eli Lilly and Company Revenue in Neuropathic Pain Management Business (2014-2019)
12.5.5 Eli Lilly and Company Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Company Details
12.6.2 Company Description and Business Overview
12.6.3 Neuropathic Pain Management Introduction
12.6.4 Bristol-Myers Squibb Revenue in Neuropathic Pain Management Business (2014-2019)
12.6.5 Bristol-Myers Squibb Recent Development
12.7 Biogen Idec
12.7.1 Biogen Idec Company Details
12.7.2 Company Description and Business Overview
12.7.3 Neuropathic Pain Management Introduction
12.7.4 Biogen Idec Revenue in Neuropathic Pain Management Business (2014-2019)
12.7.5 Biogen Idec Recent Development
12.8 Baxter Healthcare Corporation
12.8.1 Baxter Healthcare Corporation Company Details
12.8.2 Company Description and Business Overview
12.8.3 Neuropathic Pain Management Introduction
12.8.4 Baxter Healthcare Corporation Revenue in Neuropathic Pain Management Business (2014-2019)
12.8.5 Baxter Healthcare Corporation Recent Development
12.9 Depomed
12.9.1 Depomed Company Details
12.9.2 Company Description and Business Overview
12.9.3 Neuropathic Pain Management Introduction
12.9.4 Depomed Revenue in Neuropathic Pain Management Business (2014-2019)
12.9.5 Depomed Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Neuropathic Pain Management Key Market Segments
Table Key Players Neuropathic Pain Management Covered
Table Global Neuropathic Pain Management Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Tricyclic Antidepressant Figures
Table Key Players of Tricyclic Antidepressant
Figuer Anticonvulsant Figures
Table Key Players of Anticonvulsant
Figuer Opioid Figures
Table Key Players of Opioid
Figuer Steroid Drug Figures
Table Key Players of Steroid Drug
Figuer Local Anesthesia Figures
Table Key Players of Local Anesthesia
Figuer Other Figures
Table Key Players of Other
Table Global Neuropathic Pain Management Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Neuropathic Pain Management Market Share by Application in 2018 & 2025
Figure Retail Pharmacy Case Studies
Figure Hospital Pharmacy Case Studies
Figure Other Case Studies
Figure Neuropathic Pain Management Report Years Considered
Figure Global Neuropathic Pain Management Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Neuropathic Pain Management Market Size by Regions 2019-2025 (Million US$)
Table Global Neuropathic Pain Management Market Size by Regions 2019-2025 (Million US$)
Table Global Neuropathic Pain Management Market Share by Regions 2014-2019
Figure Global Neuropathic Pain Management Market Share by Regions 2014-2019
Figure Global Neuropathic Pain Management Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Neuropathic Pain Management Revenue by by Players (2014-2019) (Million US$)
Table Global Neuropathic Pain Management Market Share by by Players (2014-2019)
Figure Global Neuropathic Pain Management Market Share by by Players in 2018
Table Global Neuropathic Pain Management by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Neuropathic Pain Management Product/Solution/Service
Table Date of Enter into Neuropathic Pain Management Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Neuropathic Pain Management Market Size by Type (2014-2019) (Million US$)
Table Global Neuropathic Pain Management Market Size Share by Type (2014-2019)
Figure Global Neuropathic Pain Management Market Size Market Share by Type (2014-2019)
Table Global Neuropathic Pain Management Market Size by Application (2014-2019) (Million US$)
Table Global Neuropathic Pain Management Market Size Share by Application (2014-2019)
Figure Global Neuropathic Pain Management Market Size Market Share by Application (2014-2019)
Figure Global Neuropathic Pain Management Revenue Market Share by Application in 2018
Figure North America Neuropathic Pain Management Market Size 2014-2019 (Million US$)
Table North America Key Players Neuropathic Pain Management Revenue (2018-2019) (Million US$)
Table North America Key Players Neuropathic Pain Management Market Share (2018-2019)
Table North America Neuropathic Pain Management Market Size by Type 2014-2019 (Million US$)
Table North America Neuropathic Pain Management Market Share by Type 2014-2019
Table North America Neuropathic Pain Management Market Size by Application 2014-2019 (Million US$)
Table North America Neuropathic Pain Management Market Share by Application 2014-2019
Figure Europe Neuropathic Pain Management Market Size 2014-2019 (Million US$)
Table Europe Key Players Neuropathic Pain Management Revenue (2018-2019) (Million US$)
Table Europe Key Players Neuropathic Pain Management Market Share (2018-2019)
Table Europe Neuropathic Pain Management Market Size by Type 2014-2019 (Million US$)
Table Europe Neuropathic Pain Management Market Share by Type 2014-2019
Table Europe Neuropathic Pain Management Market Size by Application 2014-2019 (Million US$)
Table Europe Neuropathic Pain Management Market Share by Application 2014-2019
Figure China Neuropathic Pain Management Market Size 2014-2019 (Million US$)
Table China Key Players Neuropathic Pain Management Revenue (2018-2019) (Million US$)
Table China Key Players Neuropathic Pain Management Market Share (2018-2019)
Table China Neuropathic Pain Management Market Size by Type 2014-2019 (Million US$)
Table China Neuropathic Pain Management Market Share by Type 2014-2019
Table China Neuropathic Pain Management Market Size by Application 2014-2019 (Million US$)
Table China Neuropathic Pain Management Market Share by Application 2014-2019
Figure Japan Neuropathic Pain Management Market Size 2014-2019 (Million US$)
Table Japan Key Players Neuropathic Pain Management Revenue (2018-2019) (Million US$)
Table Japan Key Players Neuropathic Pain Management Market Share (2018-2019)
Table Japan Neuropathic Pain Management Market Size by Type 2014-2019 (Million US$)
Table Japan Neuropathic Pain Management Market Share by Type 2014-2019
Table Japan Neuropathic Pain Management Market Size by Application 2014-2019 (Million US$)
Table Japan Neuropathic Pain Management Market Share by Application 2014-2019
Figure Southeast Asia Neuropathic Pain Management Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Neuropathic Pain Management Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Neuropathic Pain Management Market Share (2018-2019)
Table Southeast Asia Neuropathic Pain Management Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Neuropathic Pain Management Market Share by Type 2014-2019
Table Southeast Asia Neuropathic Pain Management Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Neuropathic Pain Management Market Share by Application 2014-2019
Figure India Neuropathic Pain Management Market Size 2014-2019 (Million US$)
Table India Key Players Neuropathic Pain Management Revenue (2018-2019) (Million US$)
Table India Key Players Neuropathic Pain Management Market Share (2018-2019)
Table India Neuropathic Pain Management Market Size by Type 2014-2019 (Million US$)
Table India Neuropathic Pain Management Market Share by Type 2014-2019
Table India Neuropathic Pain Management Market Size by Application 2014-2019 (Million US$)
Table India Neuropathic Pain Management Market Share by Application 2014-2019
Figure Central & South America Neuropathic Pain Management Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Neuropathic Pain Management Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Neuropathic Pain Management Market Share (2018-2019)
Table Central & South America Neuropathic Pain Management Market Size by Type 2014-2019 (Million US$)
Table Central & South America Neuropathic Pain Management Market Share by Type 2014-2019
Table Central & South America Neuropathic Pain Management Market Size by Application 2014-2019 (Million US$)
Table Central & South America Neuropathic Pain Management Market Share by Application 2014-2019
Table Pfizer Company Details
Table Pfizer Revenue in Neuropathic Pain Management Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in Neuropathic Pain Management Business (2014-2019)
Table Pfizer Recent Development
Table Johnson & Johnson Services Company Details
Table Johnson & Johnson Services Revenue in Neuropathic Pain Management Business 2014-2019 (Million US$)
Figure Johnson & Johnson Services Revenue Growth Rate in Neuropathic Pain Management Business (2014-2019)
Table Johnson & Johnson Services Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Neuropathic Pain Management Business 2014-2019 (Million US$)
Figure Sanofi Revenue Growth Rate in Neuropathic Pain Management Business (2014-2019)
Table Sanofi Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Neuropathic Pain Management Business 2014-2019 (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Neuropathic Pain Management Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Neuropathic Pain Management Business 2014-2019 (Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Neuropathic Pain Management Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Neuropathic Pain Management Business 2014-2019 (Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Neuropathic Pain Management Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Biogen Idec Company Details
Table Biogen Idec Revenue in Neuropathic Pain Management Business 2014-2019 (Million US$)
Figure Biogen Idec Revenue Growth Rate in Neuropathic Pain Management Business (2014-2019)
Table Biogen Idec Recent Development
Table Baxter Healthcare Corporation Company Details
Table Baxter Healthcare Corporation Revenue in Neuropathic Pain Management Business 2014-2019 (Million US$)
Figure Baxter Healthcare Corporation Revenue Growth Rate in Neuropathic Pain Management Business (2014-2019)
Table Baxter Healthcare Corporation Recent Development
Table Depomed Company Details
Table Depomed Revenue in Neuropathic Pain Management Business 2014-2019 (Million US$)
Figure Depomed Revenue Growth Rate in Neuropathic Pain Management Business (2014-2019)
Table Depomed Recent Development
Table Global Neuropathic Pain Management Market Size by Regions (Million US$) 2019-2025
Figure Global Neuropathic Pain Management Market Size Share by Regions (2019-2025)
Figure Global Neuropathic Pain Management Market Size Share by Regions in 2025
Figure North America Neuropathic Pain Management Market Size Forecast (2019-2025)(Million USD)
Figure Europe Neuropathic Pain Management Market Size Forecast (2019-2025)(Million USD)
Figure China Neuropathic Pain Management Market Size Forecast (2019-2025)(Million USD)
Figure Japan Neuropathic Pain Management Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Neuropathic Pain Management Market Size Forecast (2019-2025)(Million USD)
Figure India Neuropathic Pain Management Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Neuropathic Pain Management Market Size Forecast (2019-2025)(Million USD)
Table Global Neuropathic Pain Management Market Size by Product (2019-2025) (Million US$)
Figure Global Neuropathic Pain Management Market Size by Product (2019-2025)
Figure Global Neuropathic Pain Management Market Size by Product in 2025
Table Global Neuropathic Pain Management Market Size by Application (2019-2025) (Million US$)
Figure Global Neuropathic Pain Management Market Size by Application (2019-2025)
Figure Global Neuropathic Pain Management Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
術後疼痛管理の世界市場：市場規模・現状・予測 Postoperative pain management aims to minimise patient discomfort, facilitate early mobilization and functional recovery, and prevent acute pain developing into chronic pain. Mental health can affect a patient’s recovery and psychological vulnerability is predictive of severe postoperative pain. Edu…- 術後疼痛管理の世界市場：市場規模・現状・予測 Post-operative pain management is a branch of the that deals with the minimizing the pain occur due to tissue injury together with muscle spasm to the patients after surgery. It is the branch of pain management.Global post- operative pain management market is growing steadily due to increasing deman…
- 獣医疼痛管理の世界市場：市場規模・現状・予測 Outpatient veterinary pain management centers and practitioners are actively taking a role in treating many “problematic” issues which plague veterinary patients.North America dominated the veterinary pain management market, followed by Europe. In North America, the US is expected to hold the larges…
- 獣医疼痛管理の世界市場：市場規模・現状・予測 Outpatient veterinary pain management centers and practitioners are actively taking a role in treating many “problematic” issues which plague veterinary patients.North America dominated the veterinary pain management market, followed by Europe. In North America, the US is expected to hold the larges…
- 世界の疼痛管理製品市場：専門的調査 Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. The classification of pain management drugs includes Opioids and Non-narcotic Analgesics. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, a…